<DOC>
	<DOCNO>NCT01415739</DOCNO>
	<brief_summary>This research study protein tumor sample patient non-small cell lung cancer . Finding specific protein tumor tissue sample patient cancer may help doctor tell type lung cancer patient plan well treatment .</brief_summary>
	<brief_title>Study Proteins Tumor Samples From Patients With Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To validate novel 4-protein signature 's ability subtype non-small cell lung cancer ( NSCLC ) treatment-naive , multi-institutional cohort , Cancer Leukemia Group B ( CALGB ) 9761 . SECONDARY OBJECTIVES : I . To estimate NSCLC misclassification rate multi-institutional clinical-trial setting stage 1 NSCLC ( adenocarcinoma versus squamous cell ) . OUTLINE : Previously collect tissue sample analyze via hematoxylin eosin ( H &amp; E ) stain immunohistochemistry ( IHC ) .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Patients must register CALGB9761 Stage I disease Treatmentnaive patient A representative paraffin block primary tumor must available patient CALGB9761 submit CALGB Pathology Coordinating Office A separate consent form require study , permission research perform tissue block include consent form CALGB 9761 Institutional review board ( IRB ) review approval institution laboratory work perform require</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stage IA non-small cell lung cancer</keyword>
	<keyword>stage IB non-small cell lung cancer</keyword>
	<keyword>adenocarcinoma lung</keyword>
	<keyword>squamous cell lung cancer</keyword>
</DOC>